Skip to main content
SpringerLink
Log in

Pulmonary Arterial Hypertension: Genetics and Gene Therapy

  • Chapter
Congenital Diseases in the Right Heart

  • 1069 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Gaine SP, Rubin LJ. Primary pulmonary hypertension. Lancet. 1998;352:719–25.

    Article  PubMed  CAS  Google Scholar 

  2. Widlitz A, Barst RJ. Pulmonary arterial hypertension in children. Eur Respir J. 2003;21:155–76.

    Article  PubMed  CAS  Google Scholar 

  3. Farber HW, Loscalzo J. Pulmonary arterial hypertension. N Engl J Med. 1004;351:1655–65.

    Google Scholar 

  4. Kugathasan L, Dutly AE, Zhao YD, et al. Role of angiopoietin-1 in experimental and human arterial hypertension. Chest. 2005;128:633S–642S.

    Article  PubMed  CAS  Google Scholar 

  5. Zhao YD, Campbell AI, Robb M, Ng D, Stewart DJ. Protective role of angiopoietin-1 in experimental pulmonary hypertension. Circ Res. 2003;92:984–91.

    Article  PubMed  CAS  Google Scholar 

  6. Wagenvoort CA, Wagenvoort N. Primary pulmonary hypertension. A pathological study of the lung vessels in 156 clinically diagnosed cases. Circulation. 1970;42:1163–84.

    Google Scholar 

  7. Lee SD, Shroyer KR, Markham NE, et al. Monoclonal endothelial cell proliferation is present in primary but not secondary pulmonary hypertension. J Clin Invest. 1998;101:927–34.

    Article  PubMed  CAS  Google Scholar 

  8. Stewart DJ. Bone morphogenic protein receptor-2 and pulmonary arterial hypertension. Unraveling a riddle inside an enigma? Cir Res. 2005;96:1033–35.

    CAS  Google Scholar 

  9. Taraseviciene-Stewart L, Kasahara Y, Alger L, et al. Inhibition of the VEGF receptor 2 combined with chronic hypoxia causes cell death-dependent pulmonary endothelial cell proliferation and severe pulmonary hypertension. FASEB J. 2001;15:427–38.

    Article  PubMed  CAS  Google Scholar 

  10. Nichols WC, Koller DL, Slovis B, et al. Localization of the gene for familial primary pulmonary hypertension to chromosome 2q31-32. Nat Genet. 1997;15:277–80.

    Article  PubMed  CAS  Google Scholar 

  11. Lane KB, Machado RD, Pauciulo MW, et al. Heterozygous germline mutations in BMPR2, encoding a TGF-beta receptor, cause familial primary pulmonary hypertension. The International PPH Consortium. Nat Genet. 2000;26:81–4.

    Article  PubMed  CAS  Google Scholar 

  12. Machado RD, Pauciulo MW, Thomson JR, et al. BMPR2 haploinsufficiency as the inherited molecular mechanism for primary pulmonary hypertension. Am J Hum Genet. 2001;68:92–102.

    Article  PubMed  CAS  Google Scholar 

  13. Deng Z, Morse JH, Slager SL, et al. Familial primary pulmonary hypertension (gene PPH1) is caused by mutations in the bone morphogenetic protein receptor-II gene. Am J Hum Genet. 2000;67:737–44.

    Article  PubMed  CAS  Google Scholar 

  14. Newman JH, Wheeler L, Lane KB, et al. Mutation in the gene for bone morphogenetic protein receptor II as a cause of primary pulmonary hypertension in a large kindred. N Engl J Med. 2001;345:319–24. [Errata, N Engl J Med. 2001;345:1506, 2002;346:1258.]

    Article  PubMed  CAS  Google Scholar 

  15. Newman JH, Trembath RC, Morse JA, et al. Genetic basis of pulmonary arterial hypertension: current understanding and future directions. J Am Coll Cardiol. 2004;43:Suppl S:33S–39S.

    Article  PubMed  CAS  Google Scholar 

  16. Yuan JX, Rubin LJ. Pathogenesis of pulmonary arterial hypertension. The need for multiple hits. Circulation. 2005;111:534–38.

    Article  PubMed  Google Scholar 

  17. Shi Y, Massague J. Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell. 2003;113:685–700.

    Article  PubMed  CAS  Google Scholar 

  18. Zhang S, Fantozzi I, Tigno DD, et al. Bone morphogenetic proteins induce apoptosis in human pulmonary vascular smooth muscle cells. Am J Physiol Lung Cell Mol Physiol. 2003;285:L740–54.

    PubMed  CAS  Google Scholar 

  19. Morrell NW, Yang X, Upton PD, et al. Altered growth responses of pulmonary artery smooth muscle cells from patients with primary pulmonary hypertension to transforming growth factor-beta(1) and bone morphogenetic proteins. Circulation. 2001;104:790–5.

    Article  PubMed  CAS  Google Scholar 

  20. Teichert-Kuliszewska K, Kutryk MJ, Kuliszewski MA, et al. Bone morphogenetic protein receptor-2 signaling promotes pulmonary arterial endothelial cell survival. Implications for loss-of-function mutations in the pathogenesis of pulmonary hypertension. Circ Res. 2006;98:209–217.

    Article  PubMed  CAS  Google Scholar 

  21. Szmitko PE, Fedak PWM, Weisel RD, et al. Endothelial Progenitor Cells: New hope for a broken heart. Circulation. 2003;107:3093–100.

    Article  PubMed  Google Scholar 

  22. Beppu H, Ishinose F, Kawai N, et al. BMPR-II heterozygous mice have mild pulmonary hypertension and an impaired pulmonary vascular remodeling response to prolonged hypoxia. Am J Physiol Lung Cell Mol Physiol. 2004;287:L1241–47.

    Article  PubMed  CAS  Google Scholar 

  23. West J, Fagan K, Steudel W, et al. Pulmonary hypertension in transgenic mice expressing a dominant-negative BMPRII gene in smooth muscle. Circ Res. 2004;94:1109–114.

    Article  PubMed  CAS  Google Scholar 

  24. Eddahibi S, Humbert M, Fadel E, et al. Serotonin transporter overexpression is responsible for pulmonary artery smooth muscle hyperplasia in primary pulmonary hypertension. J Clin Invest. 2001;108:1141–50.

    PubMed  CAS  Google Scholar 

  25. Harrison RE, Flanagan JA, Sankelo M, et al. Molecular and functional analysis identifies ALK-1 as the predominant cause of pulmonary hypertension related to hereditary haemorrhagic telangiectasia. J Med Genet. 2003;40:865–71.

    Article  PubMed  CAS  Google Scholar 

  26. Gale NW, Yancopoulos GD. Growth factors acting via endothelial cell-specific receptor tyrosine kinases: VEGFs, angiopoietins, and ephrins in vascular development. Genes Dev. 1999;13:1055–66.

    Article  PubMed  CAS  Google Scholar 

  27. Kim I, Kim HG, So JN, et al. Angiopoietin-1 regulates endothelial cell survival through the phosphatidylinositol 3’-kinase/Akt signal transduction pathway. Circ Res. 2000;86:24–9.

    PubMed  CAS  Google Scholar 

  28. Verma S, Anderson TJ. Fundamentals of endothelial function for the clinical cardiologist. Circulation. 2002;105:546–9.

    Article  PubMed  CAS  Google Scholar 

  29. Christman BW, McPherson CD, Newman JH, et al. An imbalance between the excretion of thromboxane and prostacyclin metabolites in pulmonary hypertension. N Engl J Med. 1992;327:70–5.

    PubMed  CAS  Google Scholar 

  30. Giadi A, Saleh D. Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension. N Engl J Med. 1995;333:214–21.

    Article  Google Scholar 

  31. Giaid A, Yanagisawa M, Langleben D, et al. Expression of endothelin-1 in the lungs of patients with pulmonary hypertension. N Engl J Med. 1993;328:1732–39.

    Article  PubMed  CAS  Google Scholar 

  32. Humbert M, Sitbon O, Simonneau G. Treatment of pulmonary arterial hypertension. N Engl J Med. 2004:351:1425–36.

    Article  PubMed  CAS  Google Scholar 

  33. Han RN, Stewart DJ. Defective lung vascular development in endothelial nitric oxide synthase-deficient mice. Trends Cardiovasc Med. 2006;16:29–34.

    Article  PubMed  CAS  Google Scholar 

  34. Aicher A, Heeschen C, Mildner-Rihm C, et al. Essential role of endothelial nitric oxide synthase for mobilzation of stem and progenitor cells. Nat Med. 2003;9:1370–76.

    Article  PubMed  CAS  Google Scholar 

  35. Ziche M, Morbidelli L, Choudhuri R, et al. Nitric oxide synthase lies downstream from vascular endothelial growth factor-induced but not basic fibroblast growth factor-induced angiogenesis. J Clin Invest. 1997;99:2625–34.

    Article  PubMed  CAS  Google Scholar 

  36. Han RN, Babaei S, Robb M, et al. Defective lung vascular development and fatal respiratory distress in endothelial NO synthase-deficient mice: A model of alveolar capillary dysplasia? Circ Res. 2004;94:1115–23.

    Article  PubMed  CAS  Google Scholar 

  37. Sato J, Nair K, Hiddinga J, et al. eNOS gene transfer to vascular smooth muscle cells inhibits cell proliferation via upregulation of p27 and p21 and not apoptosis. Cardiovasc Res. 2000;47:697–706.

    Article  PubMed  CAS  Google Scholar 

  38. Ambalavanan N, Mariani G, Bulger A, Philips JB III. Role of nitric oxide in regulating neonatal procine pulmonary artery smooth muscle cell proliferation. Biol Neonate. 1999;76:291–300.

    Article  PubMed  CAS  Google Scholar 

  39. Clapp LH, Finney P, Turcato S, et al. Differential effects of stable prostacyclin analogues on smooth muscle proliferation and cyclic AMP generation in human pulmonary artery. Am J Respir Cell Mol Biol. 2002;26:194–201.

    PubMed  CAS  Google Scholar 

  40. Tuder RM, Coo CD, Geraci MW, et al. Prostacyclin synthase expression is decreased in lungs from patients with severe pulmonary hypertension. Am J Respir Crit Care Med. 1999;159:1925–32.

    PubMed  CAS  Google Scholar 

  41. Hassoun PM, Thappa V, Landman MJ, Fanburg BL. Endothelin 1 mitogenic activity on pulmonary artery smooth muscle cells and release from hypoxic endothelial cells. Proc Soc Exp Biol Med. 1992;199:165–70.

    PubMed  CAS  Google Scholar 

  42. Nagaya N, Yokoyama C, Kyotani S, et al. Gene transfer of human prostacyclin synthase ameliorates monocrotaline-induced pulmonary hypertension in rats. Circulation. 2000;102:2005–2010.

    PubMed  CAS  Google Scholar 

  43. Campbell AI, Zhao Y, Sandu R, Stewart DJ. Cell-based gene transfer of vascular endothelial growth factor attenuates monocrotaline-induced pulmonary hypertension. Circulation. 2001;104:2242–48.

    Article  PubMed  CAS  Google Scholar 

  44. Campbell AI, Kuliszewski MA, Stewart DJ. Cell-based gene transfer to the pulmonary vasculature: endothelial nitric oxide synthase overexpression inhibits monocrotaline-induced pulmonary hypertension. Am J Respir Cell Mol Biol. 1999;21:567–75.

    PubMed  CAS  Google Scholar 

  45. Zhao YD, Courtman DW, Ng DS, et al. Microvascular regeneration in established pulmonary hypertension by angiogenic gene transfer. Am J Respir Cell Mol Biol. 2006;35:182–89.

    Article  PubMed  CAS  Google Scholar 

  46. Nagaya N, Kangawa K, Kanda M, et al. Hybrid cell-gene therapy for pulmonary hypertension based on phagocytosing action of endothelial progenitor cells. Circulation. 2003;108:889–95.

    Article  PubMed  CAS  Google Scholar 

  47. Zhao YD, Courtman DW, Deng Y, et al. Rescue of monocrotaline-induced pulmonary arterial hypertension using bone marrow-derived endothelial-like progenitor cells. Efficacy of combined cell and eNOS gene therapy in established disease. Circ Res. 2005;96:442–50.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Internal Medicine, St Michael’s Hospital, University of Toronto, Toronto, ON, Canada

    Paul E. Szmitko

Authors
  1. Paul E. Szmitko
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Duncan J. Stewart
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. The Labatt Family Heart Centre, The Hospital for Sick Children, Toronto, Canada

    Andrew N. Redington  & Glen S. Van Arsdell  & 

  2. Cardiac Unit, Institute of Child Health, University College London, London, UK

    Robert H. Anderson

Rights and permissions

Reprints and permissions

Copyright information

© 2009 Springer-Verlag London Limited

About this chapter

Cite this chapter

Szmitko, P.E., Stewart, D.J. (2009). Pulmonary Arterial Hypertension: Genetics and Gene Therapy. In: Redington, A.N., Van Arsdell, G.S., Anderson, R.H. (eds) Congenital Diseases in the Right Heart. Springer, London. https://doi.org/10.1007/978-1-84800-378-1_6

Download citation

  • DOI: https://doi.org/10.1007/978-1-84800-378-1_6

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-84800-377-4

  • Online ISBN: 978-1-84800-378-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation